SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 29th, 2021 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 1, 2021, between SciSparc Ltd., a company organized under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 29th, 2021 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 5, 2021 by and between Tauriga Sciences, Inc., a Florida corporation, with headquarters located at 4 Nancy Court, Suite 4, Wappingers Falls, NY 12590 (the “Company”), and GS CAPITAL PARTNERS, LLC, a New York limited liability company, with its address at 30 Washington Street, Suite 5L, Brooklyn, NY 11201 (the “Buyer”).
8% FIXED CONVERTIBLE PROMISSORY NOTE OF TAURIGA SCIENCES, INC.Tauriga Sciences, Inc. • June 29th, 2021 • Medicinal chemicals & botanical products • Florida
This Note is a duly authorized Fixed Convertible Promissory Note of Tauriga Sciences, Inc., a corporation duly organized and existing under the laws of the State of Florida (the “Company”), designated as the Company’s 8% Fixed Convertible Promissory Note due October 5, 2021 (“Maturity Date”) in the face amount of $525,000 (the “Note”).
RELEASERelease • June 29th, 2021 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • California
This Release is between Aegea Biotechnologies, Inc., a Delaware corporation (“Sanarus”) and Tauriga Sciences, Inc. and its founder Seth Shaw (collectively, “Releasors”). Each of Aegea and Releasors shall collectively be deemed to be “parties” under this Agreement, and are entering into this Agreement as of the date set forth above. RECITALS
ContractConsulting Agreement • June 29th, 2021 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • New York
This Consulting Agreement (the “Agreement”) is made and entered into to be effective as June 14, 2021 (the “Effective Date”) between Mayer & Associates or its designees with offices located at NY NY (the “Consultant”) and Tauriga Sciences (TAUG) or any surviving company (‘‘the Company”). The Company and the Consultant are sometimes referred to individually, as a “Party” and collectively, as the “Parties.”
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • June 29th, 2021 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • California
This Common Stock Purchase Agreement (this “Agreement”) is made and entered into as of April __, 2020, by and among Aegea Biotechnologies, Inc., a Delaware corporation (the “Company”), and Tauriga Sciences, Inc., a Delaware corporation (“Investor”).
Consulting Agreement Medical Advisory Agreement: Field of Orthopedic Surgery ADVISORY BOARD AGREEMENT Director of Medical Practice Strategy / Director Medical (“DM”) NON AFFILIATE / NON FIDUCIARY CONSULTING POSITION Tauriga Sciences Inc.Consulting Agreement • June 29th, 2021 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • New York
SUBSCRIPTION AGREEMENT WARRANTS VistaGen Therapeutics, Inc., a Nevada corporation (the “Company”)Subscription Agreement • June 29th, 2021 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • Nevada
MEMBERHSIP UNIT PURCHASE AGREEMENTMemberhsip Unit Purchase Agreement • June 29th, 2021 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • New York
THIS MEMBERSHIP UNIT PURCHASE AGREEMENT (this “Agreement”), dated as of February 5, 2021, by and among Paz Gum LLC, a Nevada limited liability company, located at 32 Pine Tree Drive, Poughkeepsie, NY 12603 (the “Company”), and the Investor identified on the signature pages hereto (individually, an “Investor” and collectively, the “Investors”).
